nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—SLC18A2—adrenal medulla—adrenal gland cancer	0.187	0.347	CbGeAlD
Methamphetamine—SLC6A2—sympathetic nervous system—adrenal gland cancer	0.0759	0.141	CbGeAlD
Methamphetamine—SLC18A1—adrenal gland—adrenal gland cancer	0.0408	0.0756	CbGeAlD
Methamphetamine—CYP2D6—urine—adrenal gland cancer	0.0228	0.0422	CbGeAlD
Methamphetamine—SLC18A2—adrenal gland—adrenal gland cancer	0.013	0.0242	CbGeAlD
Methamphetamine—MAOB—adrenal cortex—adrenal gland cancer	0.0119	0.0221	CbGeAlD
Methamphetamine—SLC22A3—gonad—adrenal gland cancer	0.0106	0.0197	CbGeAlD
Methamphetamine—MAOA—adrenal cortex—adrenal gland cancer	0.0101	0.0188	CbGeAlD
Methamphetamine—MAOB—cardiac atrium—adrenal gland cancer	0.00984	0.0182	CbGeAlD
Methamphetamine—ADRA2C—adrenal cortex—adrenal gland cancer	0.00976	0.0181	CbGeAlD
Methamphetamine—MAOB—pituitary gland—adrenal gland cancer	0.00961	0.0178	CbGeAlD
Methamphetamine—SLC22A5—adrenal cortex—adrenal gland cancer	0.00935	0.0173	CbGeAlD
Methamphetamine—SLC22A3—adrenal gland—adrenal gland cancer	0.00928	0.0172	CbGeAlD
Methamphetamine—SLC6A2—gonad—adrenal gland cancer	0.00912	0.0169	CbGeAlD
Methamphetamine—MAOB—adrenal gland—adrenal gland cancer	0.00859	0.0159	CbGeAlD
Methamphetamine—MAOA—cardiac atrium—adrenal gland cancer	0.0084	0.0156	CbGeAlD
Methamphetamine—MAOA—pituitary gland—adrenal gland cancer	0.0082	0.0152	CbGeAlD
Methamphetamine—ADRA2C—cardiac atrium—adrenal gland cancer	0.00807	0.015	CbGeAlD
Methamphetamine—SLC6A2—adrenal gland—adrenal gland cancer	0.00795	0.0147	CbGeAlD
Methamphetamine—ADRA2C—pituitary gland—adrenal gland cancer	0.00789	0.0146	CbGeAlD
Methamphetamine—SLC22A5—cardiac atrium—adrenal gland cancer	0.00773	0.0143	CbGeAlD
Methamphetamine—SLC22A5—pituitary gland—adrenal gland cancer	0.00755	0.014	CbGeAlD
Methamphetamine—MAOA—adrenal gland—adrenal gland cancer	0.00733	0.0136	CbGeAlD
Methamphetamine—ADRA2C—adrenal gland—adrenal gland cancer	0.00704	0.0131	CbGeAlD
Methamphetamine—SLC22A5—adrenal gland—adrenal gland cancer	0.00675	0.0125	CbGeAlD
Methamphetamine—ADRA2A—gonad—adrenal gland cancer	0.00645	0.012	CbGeAlD
Methamphetamine—ADRA2A—cardiac atrium—adrenal gland cancer	0.00644	0.0119	CbGeAlD
Methamphetamine—ADRA2A—pituitary gland—adrenal gland cancer	0.00629	0.0117	CbGeAlD
Methamphetamine—ADRA2A—adrenal gland—adrenal gland cancer	0.00562	0.0104	CbGeAlD
Methamphetamine—TAAR1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0013	0.00282	CbGpPWpGaD
Methamphetamine—MAOA—Neuronal System—PRKACA—adrenal gland cancer	0.00128	0.00277	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—SDHB—adrenal gland cancer	0.00124	0.00268	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00123	0.00268	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00123	0.00267	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00122	0.00265	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00122	0.00264	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00121	0.00264	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TSHR—adrenal gland cancer	0.0012	0.0026	CbGpPWpGaD
Methamphetamine—SLC6A3—Neuronal System—PRKACA—adrenal gland cancer	0.00119	0.00257	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00118	0.00256	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00115	0.0025	CbGpPWpGaD
Methamphetamine—ADRA2B—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00115	0.00249	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00114	0.00247	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—MEN1—adrenal gland cancer	0.00113	0.00244	CbGpPWpGaD
Methamphetamine—ADRA2B—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.00111	0.0024	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—TSHR—adrenal gland cancer	0.00109	0.00236	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00108	0.00235	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00107	0.00233	CbGpPWpGaD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00107	0.00233	CbGpPWpGaD
Methamphetamine—SLC18A2—Neuronal System—BRAF—adrenal gland cancer	0.00107	0.00233	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00107	0.00232	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00104	0.00227	CbGpPWpGaD
Methamphetamine—ADRA2B—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00104	0.00227	CbGpPWpGaD
Methamphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00104	0.00225	CbGpPWpGaD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.00103	0.00224	CbGpPWpGaD
Methamphetamine—MAOA—Biological oxidations—POMC—adrenal gland cancer	0.00102	0.00222	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—TSHR—adrenal gland cancer	0.00102	0.0022	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000976	0.00212	CbGpPWpGaD
Methamphetamine—ADRA2C—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.000975	0.00212	CbGpPWpGaD
Methamphetamine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000965	0.00209	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—RRM1—adrenal gland cancer	0.000941	0.00204	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—SDHD—adrenal gland cancer	0.000941	0.00204	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000925	0.00201	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000924	0.00201	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000921	0.002	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—SDHB—adrenal gland cancer	0.000916	0.00199	CbGpPWpGaD
Methamphetamine—MAOA—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000897	0.00195	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000874	0.0019	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000873	0.00189	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.000871	0.00189	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000866	0.00188	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000859	0.00187	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00085	0.00185	CbGpPWpGaD
Methamphetamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00084	0.00182	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.000839	0.00182	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000833	0.00181	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—SPARC—adrenal gland cancer	0.000826	0.00179	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—TSHR—adrenal gland cancer	0.000824	0.00179	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—SDHD—adrenal gland cancer	0.000796	0.00173	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—RRM1—adrenal gland cancer	0.000796	0.00173	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—POMC—adrenal gland cancer	0.000794	0.00172	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000792	0.00172	CbGpPWpGaD
Methamphetamine—ADRA2A—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.000792	0.00172	CbGpPWpGaD
Methamphetamine—MAOA—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000791	0.00172	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—SPARC—adrenal gland cancer	0.000772	0.00168	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—SDHB—adrenal gland cancer	0.000754	0.00164	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000749	0.00163	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000747	0.00162	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000735	0.0016	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000733	0.00159	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CDC42—adrenal gland cancer	0.000729	0.00158	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000719	0.00156	CbGpPWpGaD
Methamphetamine—ADRA2B—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000703	0.00153	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IGF2—adrenal gland cancer	0.000702	0.00153	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—MED12—adrenal gland cancer	0.000701	0.00152	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—PRKACA—adrenal gland cancer	0.000697	0.00151	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—GNAS—adrenal gland cancer	0.000696	0.00151	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000689	0.0015	CbGpPWpGaD
Methamphetamine—MAOA—Neuronal System—BRAF—adrenal gland cancer	0.000687	0.00149	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000679	0.00147	CbGpPWpGaD
Methamphetamine—ADRA2C—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000657	0.00143	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—PRKACA—adrenal gland cancer	0.000651	0.00141	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000644	0.0014	CbGpPWpGaD
Methamphetamine—SLC6A3—Neuronal System—BRAF—adrenal gland cancer	0.000639	0.00139	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000637	0.00138	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—GNAS—adrenal gland cancer	0.000632	0.00137	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—SPARC—adrenal gland cancer	0.000627	0.00136	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000626	0.00136	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—GNRHR—adrenal gland cancer	0.000617	0.00134	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000614	0.00133	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—SDHB—adrenal gland cancer	0.000612	0.00133	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—MED12—adrenal gland cancer	0.000593	0.00129	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—CDC42—adrenal gland cancer	0.000592	0.00128	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—GNAS—adrenal gland cancer	0.00059	0.00128	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—RRM1—adrenal gland cancer	0.00059	0.00128	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—SDHD—adrenal gland cancer	0.00059	0.00128	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TERT—adrenal gland cancer	0.000585	0.00127	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000584	0.00127	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000583	0.00127	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—GNRHR—adrenal gland cancer	0.000576	0.00125	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000574	0.00125	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000574	0.00125	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000572	0.00124	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—IGF2—adrenal gland cancer	0.00057	0.00124	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—GNAS—adrenal gland cancer	0.000565	0.00123	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000559	0.00121	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—TSHR—adrenal gland cancer	0.000558	0.00121	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—CDC42—adrenal gland cancer	0.000553	0.0012	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000539	0.00117	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000536	0.00116	CbGpPWpGaD
Methamphetamine—ADRA2A—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000533	0.00116	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—IGF2—adrenal gland cancer	0.000533	0.00116	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—PRKACA—adrenal gland cancer	0.000529	0.00115	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—GNAS—adrenal gland cancer	0.000528	0.00115	CbGpPWpGaD
Methamphetamine—SLC6A4—Circadian rythm related genes—TP53—adrenal gland cancer	0.000524	0.00114	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000523	0.00113	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000522	0.00113	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—TSHR—adrenal gland cancer	0.000521	0.00113	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000516	0.00112	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PRKACA—adrenal gland cancer	0.000512	0.00111	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—BAD—adrenal gland cancer	0.000509	0.0011	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000507	0.0011	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000504	0.00109	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—SDHD—adrenal gland cancer	0.000486	0.00105	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—RRM1—adrenal gland cancer	0.000486	0.00105	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00048	0.00104	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000475	0.00103	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—POMC—adrenal gland cancer	0.000469	0.00102	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.000468	0.00102	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000466	0.00101	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—BRAF—adrenal gland cancer	0.000463	0.00101	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—CDC42—adrenal gland cancer	0.000449	0.000974	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000449	0.000974	CbGpPWpGaD
Methamphetamine—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.000446	0.000968	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—MED12—adrenal gland cancer	0.00044	0.000956	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000435	0.000945	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PRKACA—adrenal gland cancer	0.000433	0.00094	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IGF2—adrenal gland cancer	0.000433	0.000939	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—GNAS—adrenal gland cancer	0.000429	0.000931	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—POMC—adrenal gland cancer	0.000426	0.000924	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000424	0.000921	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.000423	0.000919	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—GNAS—adrenal gland cancer	0.000415	0.0009	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000409	0.000888	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—ABCB1—adrenal gland cancer	0.000407	0.000884	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0004	0.000869	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.000399	0.000866	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—POMC—adrenal gland cancer	0.000398	0.000863	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—RRM1—adrenal gland cancer	0.000394	0.000856	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—SDHD—adrenal gland cancer	0.000394	0.000856	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000374	0.000812	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000374	0.000812	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—GNRH1—adrenal gland cancer	0.00037	0.000802	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—MED12—adrenal gland cancer	0.000362	0.000786	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000357	0.000776	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—GNAS—adrenal gland cancer	0.000351	0.000762	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000349	0.000758	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—GNRH1—adrenal gland cancer	0.000345	0.00075	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ABCB1—adrenal gland cancer	0.000344	0.000748	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CDC42—adrenal gland cancer	0.000339	0.000737	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000338	0.000734	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000335	0.000727	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000334	0.000724	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TSHR—adrenal gland cancer	0.000329	0.000715	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000324	0.000704	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—POMC—adrenal gland cancer	0.000323	0.000701	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PRKACA—adrenal gland cancer	0.000321	0.000697	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CDC42—adrenal gland cancer	0.000317	0.000688	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SPRY2—adrenal gland cancer	0.000316	0.000686	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MEN1—adrenal gland cancer	0.00031	0.000672	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TSHR—adrenal gland cancer	0.000308	0.000668	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000304	0.000659	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—GNAS—adrenal gland cancer	0.000303	0.000658	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—MED12—adrenal gland cancer	0.000294	0.000638	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MEN1—adrenal gland cancer	0.000289	0.000628	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000284	0.000616	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.00028	0.000609	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—POMC—adrenal gland cancer	0.000279	0.000606	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000271	0.000588	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—EGFR—adrenal gland cancer	0.000265	0.000576	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PRKACA—adrenal gland cancer	0.000264	0.000573	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GNAS—adrenal gland cancer	0.00026	0.000565	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000258	0.000559	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000257	0.000558	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000257	0.000558	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000256	0.000557	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ABCB1—adrenal gland cancer	0.000255	0.000554	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TSHR—adrenal gland cancer	0.00025	0.000543	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000246	0.000534	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000241	0.000522	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000236	0.000513	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—POMC—adrenal gland cancer	0.000236	0.000513	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000235	0.00051	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000225	0.000488	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTGS2—adrenal gland cancer	0.000223	0.000484	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TP53—adrenal gland cancer	0.000223	0.000483	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000221	0.000479	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—POMC—adrenal gland cancer	0.000218	0.000474	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	0.000215	0.000466	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GNAS—adrenal gland cancer	0.000214	0.000465	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ABCB1—adrenal gland cancer	0.00021	0.000456	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000204	0.000443	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CDC42—adrenal gland cancer	0.000201	0.000435	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000193	0.00042	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000192	0.000416	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000192	0.000416	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTGS2—adrenal gland cancer	0.000188	0.000409	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000187	0.000407	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000187	0.000406	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000182	0.000396	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TP53—adrenal gland cancer	0.000181	0.000392	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000181	0.000392	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000179	0.000389	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000179	0.000389	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—POMC—adrenal gland cancer	0.000175	0.00038	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000175	0.000379	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GNAS—adrenal gland cancer	0.000174	0.000377	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	0.000171	0.00037	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TP53—adrenal gland cancer	0.000169	0.000366	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000166	0.00036	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TERT—adrenal gland cancer	0.000161	0.000349	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000152	0.00033	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TERT—adrenal gland cancer	0.00015	0.000326	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000147	0.000318	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000145	0.000316	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—POMC—adrenal gland cancer	0.000144	0.000313	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000142	0.000308	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—BAD—adrenal gland cancer	0.00014	0.000304	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.00014	0.000303	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS2—adrenal gland cancer	0.00014	0.000303	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TP53—adrenal gland cancer	0.000137	0.000298	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—BAD—adrenal gland cancer	0.000131	0.000284	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—POMC—adrenal gland cancer	0.000129	0.00028	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000127	0.000277	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000123	0.000268	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000122	0.000265	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—POMC—adrenal gland cancer	0.000121	0.000262	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000119	0.000258	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—POMC—adrenal gland cancer	0.000117	0.000254	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000115	0.00025	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS2—adrenal gland cancer	0.000115	0.00025	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000113	0.000246	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000111	0.000241	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	0.000106	0.000231	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	9.79e-05	0.000213	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	9.67e-05	0.00021	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	9.37e-05	0.000203	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	9.34e-05	0.000203	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	9.21e-05	0.0002	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CTNNB1—adrenal gland cancer	8.6e-05	0.000187	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—POMC—adrenal gland cancer	7.63e-05	0.000166	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—EGFR—adrenal gland cancer	7.29e-05	0.000158	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	6.99e-05	0.000152	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—EGFR—adrenal gland cancer	6.81e-05	0.000148	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TP53—adrenal gland cancer	6.12e-05	0.000133	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	6.08e-05	0.000132	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TP53—adrenal gland cancer	5.72e-05	0.000124	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	5.53e-05	0.00012	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	4.65e-05	0.000101	CbGpPWpGaD
